Allist and ArriVent Announce Interim Results from Ongoing Ph

Allist and ArriVent Announce Interim Results from Ongoing Phase 1b Trial with Furmonertinib at the 2023 World Conference on Lung Cancer

Allist and ArriVent Announce Interim Results from Ongoing Phase 1b Trial with Furmonertinib at the 2023 World Conference on Lung Cancer

forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Shanghai , China , Zhangjiang , Zhejiang , Baohui Han , Arrivent Biopharma , Guo Jianhui , Allist Pharmaceuticals , Arrivent Biopharma Inc , Shanghai Stock Exchange On , United States National Institutes Of Health , Shanghai Allist Pharmaceuticals Co Ltd , Allist Pharmaceuticals Co Ltd , Professor Baohui Han , Shanghai Chest Hospital , Lung Cancer , International Association , United States National Institutes , Zhangjiang Hi Tech Park , Sci Tech Innovation Board , Shanghai Stock Exchange ,